Robitussin Recalls Cough Syrup Contaminated with Unsafe Yeast Levels

Haleon, the maker of Robitussin cough syrup, has issued a voluntary recall due to potential microbial contamination. The recall specifically affects two Robitussin products – Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. According to the company, there haven’t been any reports of adverse events related to the recall.

The concern is that ingestion of the affected products could result in severe or life-threatening adverse events, particularly in individuals with weakened immune systems. These events include the presence of fungi or yeasts in the blood, known as fungemia, or disseminated fungal infection. However, for non-immunocompromised individuals, the risk of life-threatening infections is low.

Haleon is taking proactive measures by notifying distributors and customers directly to return the recalled products. The recall is being carried out with the knowledge and cooperation of the U.S. Food and Drug Administration.

This recall focuses on eight specific lots of Robitussin cough syrup, and the products have expiration dates ranging from October 2025 to June 2026. It is imperative for those who have purchased these specific products to return them promptly.

The company advises anyone who has used the affected cough syrup and is experiencing any related problems to contact a healthcare provider. Additionally, users can report any issues to the FDA’s online reporting system.

It is important to note that the levels of yeast detected in the contaminated syrup are beyond the allowed measurements. While yeast is a natural component of honey, these higher levels pose a potential risk, especially to individuals with compromised immune systems. Millions of people in the U.S. fall into this category, including organ transplant recipients and those with HIV.

The recall by Robitussin’s parent company, Haleon, is aimed at ensuring the safety and well-being of consumers. So far, there have been no reports of injuries or infections linked to the affected products.

Robitussin is a widely recognized brand known for its cough and cold remedies. Haleon, based in the U.K. with its U.S. headquarters in New Jersey, is committed to addressing this issue promptly and efficiently.